Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Pre-Tax Profit Margin 2010-2024 | MKKGY

Current and historical pre-tax profit margin for Merck (MKKGY) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Merck pre-tax profit margin for the three months ending September 30, 2024 was .
  
Merck Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $22.74B $3.66B 16.09%
2024-06-30 $22.58B $3.53B 15.64%
2024-03-31 $22.60B $3.66B 16.20%
2023-12-31 $22.72B $3.77B 16.60%
2023-09-30 $22.91B $3.93B 17.15%
2023-06-30 $23.13B $4.11B 17.75%
2023-03-31 $23.27B $4.33B 18.58%
2022-12-31 $23.42B $4.52B 19.28%
2022-09-30 $23.58B $4.80B 20.37%
2022-06-30 $23.60B $4.78B 20.25%
2022-03-31 $23.54B $4.74B 20.11%
2021-12-31 $23.29B $4.64B 19.93%
2021-09-30 $22.79B $4.16B 18.25%
2021-06-30 $22.12B $4.23B 19.13%
2021-03-31 $20.79B $3.51B 16.88%
2020-12-31 $20.03B $3.00B 15.00%
2020-09-30 $19.42B $2.84B 14.64%
2020-06-30 $18.73B $2.12B 11.34%
2020-03-31 $18.66B $2.32B 12.45%
2019-12-31 $18.09B $1.94B 10.75%
2019-09-30 $17.42B $1.72B 9.89%
2019-06-30 $17.27B $1.70B 9.86%
2019-03-31 $17.24B $1.47B 8.51%
2018-12-31 $17.52B $1.73B 9.85%
2018-09-30 $17.87B $1.65B 9.22%
2018-06-30 $17.90B $2.13B 11.87%
2018-03-31 $17.75B $2.35B 13.23%
2017-12-31 $17.32B $2.52B 14.52%
2017-09-30 $16.90B $2.68B 15.88%
2017-06-30 $16.68B $2.38B 14.28%
2017-03-31 $16.70B $2.25B 13.49%
2016-12-31 $16.63B $2.38B 14.34%
2016-09-30 $16.29B $2.20B 13.50%
2016-06-30 $15.63B $2.06B 13.16%
2016-03-31 $14.89B $2.08B 13.98%
2015-12-31 $14.31B $1.65B 11.53%
2015-09-30 $13.91B $1.92B 13.80%
2015-06-30 $14.32B $1.88B 13.10%
2015-03-31 $14.59B $1.90B 13.05%
2014-12-31 $14.78B $2.07B 14.00%
2014-09-30 $15.11B $1.90B 12.60%
2014-06-30 $14.86B $1.98B 13.33%
2014-03-31 $14.80B $1.99B 13.44%
2013-12-31 $14.72B $1.84B 12.52%
2013-09-30 $14.64B $5.21B 35.59%
2013-06-30 $14.55B $4.97B 34.12%
2013-03-31 $14.30B $4.36B 30.49%
2012-12-31 $14.00B $7.19B 51.34%
2012-09-30 $13.66B $6.85B 50.15%
2012-06-30 $13.69B $10.11B 73.85%
2012-03-31 $13.85B $10.03B 72.43%
2011-12-31 $14.08B $10.26B 72.89%
2011-09-30 $14.47B $13.43B 92.78%
2011-06-30 $14.03B $10.22B 72.80%
2011-03-31 $13.05B $13.05B 100.00%
2010-12-31 $12.34B $12.34B 100.00%
2010-09-30 $11.61B $8.84B 76.13%
2010-06-30 $11.25B $11.25B 100.00%
2010-03-31 $11.14B $11.14B 100.00%
2009-12-31 $10.81B $10.81B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.559B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.370B 28.62
Chugai Pharmaceutical (CHGCY) Japan $70.231B 27.36
Takeda Pharmaceutical (TAK) Japan $41.683B 8.68
Sandoz Group AG (SDZNY) Switzerland $18.304B 0.00
Astellas Pharma (ALPMY) Japan $17.717B 16.32
United Therapeutics (UTHR) United States $16.053B 15.79
Neurocrine Biosciences (NBIX) United States $13.711B 36.31
Summit Therapeutics (SMMT) United States $13.178B 0.00
Shionogi (SGIOY) Japan $11.893B 11.91
Madrigal Pharmaceuticals (MDGL) United States $6.727B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.626B 0.00
Corcept Therapeutics (CORT) United States $5.385B 40.79
Crinetics Pharmaceuticals (CRNX) United States $4.971B 0.00
PTC Therapeutics (PTCT) United States $3.566B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.537B 11.50
Dyne Therapeutics (DYN) United States $2.441B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.411B 14.41
NewAmsterdam Pharma (NAMS) Netherlands $2.356B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.259B 0.00
Soleno Therapeutics (SLNO) United States $1.948B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.728B 0.00
Xencor (XNCR) United States $1.689B 0.00
Indivior (INDV) United States $1.608B 6.55
Evotec AG (EVO) Germany $1.584B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.568B 0.00
Guardian Pharmacy Services (GRDN) United States $1.355B 0.00
Ocular Therapeutix (OCUL) United States $1.336B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.293B 0.00
Harrow (HROW) United States $1.219B 0.00
Ardelyx (ARDX) United States $1.142B 0.00
Enliven Therapeutics (ELVN) United States $1.098B 0.00
ARS Pharmaceuticals (SPRY) United States $1.087B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.993B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.23
Bioventus (BVS) United States $0.866B 27.36
Cronos Group (CRON) Canada $0.745B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.712B 0.00
Oruka Therapeutics (ORKA) United States $0.711B 0.00
Relay Therapeutics (RLAY) United States $0.696B 0.00
USANA Health Sciences (USNA) United States $0.636B 11.80
Elite Pharmaceuticals (ELTP) United States $0.587B 0.00
Altimmune (ALT) United States $0.587B 0.00
Savara (SVRA) United States $0.554B 0.00
Tourmaline Bio (TRML) United States $0.530B 0.00
Xeris Biopharma Holdings (XERS) United States $0.520B 0.00
OmniAb (OABI) United States $0.494B 0.00
Verve Therapeutics (VERV) United States $0.486B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.472B 0.00
Zevra Therapeutics (ZVRA) United States $0.453B 0.00
ProKidney (PROK) United States $0.440B 0.00
Esperion Therapeutics (ESPR) United States $0.432B 0.00
Siga Technologies (SIGA) United States $0.422B 4.93
KalVista Pharmaceuticals (KALV) United States $0.413B 0.00
Korro Bio (KRRO) United States $0.409B 0.00
Akebia Therapeutics (AKBA) United States $0.399B 0.00
Organogenesis (ORGO) United States $0.383B 0.00
Aquestive Therapeutics (AQST) United States $0.333B 0.00
Avita Medical (RCEL) United States $0.309B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.301B 122.07
4D Molecular Therapeutics (FDMT) United States $0.292B 0.00
Aldeyra Therapeutics (ALDX) United States $0.291B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.278B 0.00
Nature's Sunshine Products (NATR) United States $0.277B 16.48
Larimar Therapeutics (LRMR) United States $0.256B 0.00
Heron Therapeutics (HRTX) United States $0.240B 0.00
Innate Pharma SA (IPHYF) France $0.233B 0.00
Profound Medical (PROF) Canada $0.218B 0.00
Inhibikase Therapeutics (IKT) United States $0.215B 0.00
Acrivon Therapeutics (ACRV) United States $0.209B 0.00
Lexeo Therapeutics (LXEO) United States $0.208B 0.00
Silence Therapeutics (SLN) United Kingdom $0.206B 0.00
Aclaris Therapeutics (ACRS) United States $0.194B 0.00
Lyell Immunopharma (LYEL) United States $0.179B 0.00
MediWound (MDWD) Israel $0.178B 0.00
Nektar Therapeutics (NKTR) United States $0.171B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.158B 0.00
Telomir Pharmaceuticals (TELO) United States $0.153B 0.00
Metagenomi (MGX) United States $0.152B 0.00
Nanobiotix S.A (NBTX) France $0.146B 0.00
CytoDyn (CYDY) United States $0.145B 0.00
VAXART, INC (VXRT) United States $0.141B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.133B 0.00
Achieve Life Sciences (ACHV) Canada $0.127B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Protara Therapeutics (TARA) United States $0.111B 0.00
Inotiv (NOTV) United States $0.106B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Regulus Therapeutics (RGLS) United States $0.104B 0.00
Champions Oncology (CSBR) United States $0.104B 0.00
Pyxis Oncology (PYXS) United States $0.101B 0.00
ElectroCore (ECOR) United States $0.100B 0.00
Journey Medical (DERM) United States $0.098B 0.00
Century Therapeutics (IPSC) United States $0.094B 0.00
Avalo Therapeutics (AVTX) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.086B 0.00
Assertio Holdings (ASRT) United States $0.085B 22.15
Karyopharm Therapeutics (KPTI) United States $0.080B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.077B 0.00
Prelude Therapeutics (PRLD) United States $0.072B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Galectin Therapeutics (GALT) United States $0.065B 0.00
Scienture Holdings (SCNX) United States $0.065B 0.00
OptiNose (OPTN) United States $0.063B 0.00
Mural Oncology (MURA) Ireland $0.054B 0.00
Swiftmerge Acquisition (ANNA) United States $0.049B 0.00
Iterum Therapeutics (ITRM) Ireland $0.049B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
AlloVir (ALVR) United States $0.047B 0.00
Nutriband (NTRB) United States $0.045B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.045B 0.00
Gain Therapeutics (GANX) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.041B 0.00
FibroGen (FGEN) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
Surrozen (SRZN) United States $0.034B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.034B 0.00
BioVie (BIVI) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.032B 0.00
Tempest Therapeutics (TPST) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
DURECT (DRRX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MEI Pharma (MEIP) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Biomerica (BMRA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Molecular Templates (MTEM) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
Jupiter Neurosciences (JUNS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.83
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 40.31